Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 200 | 100 | 0 | 0 | 0 |
| Gross Profit | 200 | 100 | N/A | N/A | N/A |
| Operating Expenses | 18,113 | 14,544 | 16,449 | 16,135 | 25,019 |
| Operating Income | -17,913 | -14,444 | -16,449 | -16,135 | -25,019 |
| Other Income | -74 | -22 | -24 | -15,699 | -22,404 |
| Pre-tax Income | -17,987 | -14,466 | -16,473 | -31,834 | -47,423 |
| Income Tax | 36 | 39 | -11 | 78 | 39 |
| Net Income Continuous | -18,023 | -14,505 | -16,462 | -31,912 | -47,462 |
| Net Income | $-18,023 | $-14,505 | $-16,462 | $-31,912 | $-47,462 |
| EPS Basic Total Ops | -1.59 | -1.39 | -1.58 | -3.14 | -8.42 |
| EPS Basic Continuous Ops | -1.59 | -1.39 | -1.58 | -3.14 | -8.43 |
| EPS Diluted Total Ops | -1.59 | -1.39 | -1.58 | -3.14 | -8.42 |
| EPS Diluted Continuous Ops | -1.59 | -1.39 | -1.58 | -3.14 | -8.43 |
| EPS Diluted Before Non-Recurring Items | -1.63 | -1.39 | N/A | N/A | N/A |
| EBITDA(a) | $-17,866 | $-14,366 | $-16,391 | $-16,080 | $-25,124 |